TylerTrimbath
Ventrus Biosciences $VTUS Completes Enrollment of Phase 3 Trial of (VEN 309) in Patients With Hemorrhoidal Disease http://t.co/dip6C1at
- About
- Help
- Blog
- Jobs
- Press
- Tools
- Mobile
- Developers
- House Rules
- For Public Companies
- For Market Professionals
-
- Terms
- Privacy
- Disclaimer
- Market Quotes provided by Xignite © 2013 StockTwits, Inc.